Gene modification of mesenchymal stem cells and articular chondrocytes to enhance chondrogenesis

21Citations
Citations of this article
53Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Current cell based treatment for articular cartilage and osteochondral defects are hampered by issues such as cellular dedifferentiation and hypertrophy of the resident or transplanted cells. The reduced expression of chondrogenic signalling molecules and transcription factors is a major contributing factor to changes in cell phenotype. Gene modification of chondrocytes may be one approach to redirect cells to their primary phenotype and recent advances in nonviral and viral gene delivery technologies have enabled the expression of these lost factors at high efficiency and specificity to regain chondrocyte function. This review focuses on the various candidate genes that encode signalling molecules and transcription factors that are specific for the enhancement of the chondrogenic phenotype and also how epigenetic regulators of chondrogenesis in the form of microRNA may also play an important role. © 2014 Saliya Gurusinghe and Padraig Strappe.

Cite

CITATION STYLE

APA

Gurusinghe, S., & Strappe, P. (2014). Gene modification of mesenchymal stem cells and articular chondrocytes to enhance chondrogenesis. BioMed Research International. Hindawi Publishing Corporation. https://doi.org/10.1155/2014/369528

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free